TSX: MFI
www.mapleleaffoods.com
Investor Contact
investor.relations@mapleleaf.com
Media Contact
media.hotline@mapleleaf.com
Maple Leaf records year-over-year Adjusted EBITDA
growth of 37% to $141 million
Company on track to meet its 2024 priorities and
execute its transformative spin-off of pork business
MISSISSAUGA, ON, Aug. 8, 2024
/CNW/ - Maple Leaf Foods Inc. ("Maple Leaf Foods" or "the Company")
(TSX: MFI) today reported its financial results for the second
quarter ended June 30, 2024.
"In the second quarter of 2024, we made excellent progress in
executing our strategic playbook, delivering Adjusted EBITDA of
$141 million, 37% growth over the
second quarter of last year, and 11.2% Adjusted EBITDA Margin, a
310 basis point improvement year over year," said Curtis Frank, President and CEO of Maple Leaf
Foods. "Several key elements contributed to our performance,
including 3.2% year-over-year sales growth in our prepared meats
business, improved pork market conditions, growth in our
sustainable meats portfolio, better overall sales mix, and
contributions from our large capital projects."
"We remain laser-focused on executing our priorities for 2024,
and we are not taking our eye off the longer-term goals we have set
for ourselves" continued Mr. Frank. "We are harvesting the benefits
from our London poultry plant and
Bacon Centre of Excellence, driving cost out of the business,
deleveraging our balance sheet, and drawing on our team's proven
ability to demonstrate agility in a challenging consumer demand
environment."
"Looking ahead, we are on a clear path to unleashing the
potential of our business by separating into two independent public
companies, each primed for growth and positioned to be a leader in
its field," stated Mr. Frank. "I am confident, that these two
companies - Maple Leaf Foods and the new Pork Company - will unlock
the value of their respective organizations for the benefit of all
stakeholders, with dedicated management teams and the financial
independence to pursue their own value creation strategies. This
will be the next exciting milestone step in executing the Maple
Leaf playbook."
Second Quarter 2024 Highlights
- Adjusted Earnings Before Interest, Taxes, Depreciation and
Amortization ("EBITDA")(i) grew to $141 million, a 37% increase from the second
quarter of last year, with Adjusted EBITDA margin increasing from
8.1% to 11.2% for the same period.
- Sales were $1,261 million for the
second quarter, compared to $1,266
million for the same period last year. Sales in Prepared
Foods increased approximately 1%. Within Prepared Foods, prepared
meats increased 3.2% which was partially offset by declines in
poultry and plant protein of 3.9% and 2.5% respectively, compared
to the same period in the prior year. Sales in the Pork operating
unit decreased by 4.2% compared to last year.
- Loss for the second quarter of 2024 was $26 million ($0.21
per basic share) compared to a loss of $54
million ($0.44 loss per basic
share) last year.
- Capital expenditures in the second quarter of 2024 were
$16 million compared to $53 million in the second quarter last year,
consistent with the Company's focus of disciplined capital
management, and reflecting the completion of its large capital
projects.
- Net Debt(i) was $1,723
million, with Net Debt to trailing four quarters Adjusted
EBITDA of 3.4x, an improvement from 3.7x at the end of the first
quarter.
- Free cash flow(i) improved to $27 million, an increase of $103 million from the same quarter last
year.
Unlocking Value through the Creation of Two Independent
Public Companies
- On July 9, 2024, Maple Leaf Foods
announced plans to separate into two independent public companies
through the spin-off of its pork business. The Company expects that
this transaction will be completed in 2025. An update to the
previously provided management's preliminary estimates of the
relative size of the two companies reflecting the last twelve
months ended June 30, 2024 can be
found in the section titled Management's Estimates on the Pork
business spin-off, and related Non-IFRS measures, in this news
release.
Outlook
- For the full year 2024, the Company expects:
- Low single-digit revenue growth
- Adjusted EBITDA margin expansion over 2023
- To generate increased free cash flow and delever the balance
sheet
- Total capital expenditures this year are expected to be in the
range of $120 - $140 million, largely focused on maintenance
capital and optimization of its existing network
(i)
|
Refer to the section
titled Non-IFRS Financial Measures in this news
release.
|
Financial Highlights
|
As at or for
the
|
|
As at or for
the
|
Measure(i)
(Unaudited)
|
Three months ended
June 30,
|
|
Six months ended
June 30,
|
|
2024
|
|
2023
|
|
Change
|
|
2024
|
|
2023
|
|
Change
|
Sales(ii)
|
|
$
1,260.9
|
|
$
1,265.8
|
|
(0.4) %
|
|
$
2,414.1
|
|
$
2,436.9
|
|
(0.9) %
|
(Loss)
Earnings
|
|
$
(26.2)
|
|
$
(53.7)
|
|
51.2 %
|
|
$
25.4
|
|
$
(111.4)
|
|
nm(iv)
|
Basic (Loss) Earnings
per Share
|
|
$
(0.21)
|
|
$
(0.44)
|
|
52.3 %
|
|
$
0.21
|
|
$
(0.92)
|
|
nm(iv)
|
Adjusted Operating
Earnings(iii)
|
|
$
78.1
|
|
$
45.9
|
|
70.3 %
|
|
$
131.1
|
|
$
65.2
|
|
101.1 %
|
Adjusted Earnings
(Loss) per Share(iii)
|
|
$
0.18
|
|
$
0.00
|
|
nm(iv)
|
|
$
0.22
|
|
$
(0.12)
|
|
nm(iv)
|
Adjusted
EBITDA(iii)
|
|
$
140.9
|
|
$
103.1
|
|
36.7 %
|
|
$
257.3
|
|
$
178.4
|
|
44.2 %
|
Adjusted
EBT(iii)
|
|
$
34.4
|
|
$
6.7
|
|
413.4 %
|
|
$
44.8
|
|
$
(7.3)
|
|
nm(iv)
|
Free Cash
Flow(iii)
|
|
$
27.0
|
|
$
(76.3)
|
|
nm(iv)
|
|
$
100.7
|
|
$
(64.0)
|
|
nm(iv)
|
Net
Debt(iii)
|
|
|
|
|
|
|
|
$
(1,723.1)
|
|
$(1,807.4)
|
|
4.7 %
|
(i)
|
All financial
measures in millions of dollars except Basic and Adjusted Earnings
per Share.
|
(ii)
|
Quarterly amounts
for 2023 have been adjusted to eliminate new sales agreements
entered into during the year that contained an expectation of
repurchase, which had previously been reported as external
sales.
|
(iii)
|
Refer to the section
titled Non-IFRS Financial Measures in this news
release.
|
(iv)
|
Not
meaningful.
|
Sales for the second quarter of 2024 were $1,260.9 million compared to $1,265.8 million last year, a decrease of 0.4%.
Sales in the Prepared Foods operating unit increased 1.0%. Within
Prepared Foods, prepared meats sales increased 3.2% which was
partially offset by declines in poultry and plant protein of 3.9%
and 2.5% respectively, compared to the same period in the prior
year. Sales in the Pork operating unit decreased by 4.2% compared
to the same period in the prior year.
Year-to-date sales for 2024 were $2,414.1
million compared to $2,436.9
million last year, a decrease of 0.9%. Prepared Foods sales
increased marginally by 0.4%, with an increase in prepared meats
sales of 3.0% largely offset by declines in poultry and plant
protein of 5.5% and 4.1%, respectively. Pork operating unit sales
declined 4.4% compared to the prior year period.
As a result of improvements in pork markets, reduction of
start-up expenses at new facilities, and improvement in operational
efficiencies, all of which were partially offset by increased
Selling, General and Administrative expenses ("SG&A"),
unrealized mark to market valuation of biological assets and
derivatives, and higher interest expense, Loss for the second
quarter of 2024 of $26.2 million
($0.21 loss per basic share) improved
compared to a loss of $53.7 million
($0.44 loss per basic share) last
year.
Year-to-date earnings for 2024 were $25.4
million ($0.21 earnings per
basic share) compared to a loss of $111.4
million ($0.92 loss per basic
share) last year. The increase was driven by improvement in pork
markets, reduction of start-up expenses at new facilities, and
improvements in operational efficiencies, unrealized mark to market
valuation of biological assets and derivatives that are reported
outside of adjusted operating earnings, and lower restructuring
charges. All partly offset by higher SG&A, interest expense,
and income taxes.
Adjusted Operating Earnings for the second quarter of 2024 were
$78.1 million compared to
$45.9 million last year, and Adjusted
Earnings per Share for the second quarter of 2024 was $0.18 compared to $0.00 last year. The increase was a result of
improved pork market conditions and operational efficiencies,
partly offset by higher SG&A.
Year-to-date Adjusted Operating Earnings for 2024 were
$131.1 million compared to
$65.2 million last year, and Adjusted
Earnings per Share for 2024 was $0.22
compared to loss of $0.12 last year
due to similar factors as noted for the second quarter above.
Adjusted Earnings Before Taxes ("Adjusted EBT") for
the second quarter of 2024 were $34.4
million compared to $6.7
million last year. Adjusted EBT was driven by improved pork
market conditions and operating efficiencies partly offset by
interest expense due to higher interest rates, and higher
SG&A.
Year-to-date Adjusted EBT for 2024 were $44.8 million compared to loss of $7.3 million last year due to similar
factors as noted above.
Free Cash Flow for the second quarter of 2024 was
$27.0 million compared to Free Cash
Flow of negative $76.3 million in the
prior year. The improvement was driven by improved earnings after
the removal of non-cash items, income tax refunds, lower
restructuring payments, and reduced investment in working capital,
combined with lower spending on maintenance capital.
Year-to-date Free Cash Flow for 2024 was $100.7 million
compared to Free Cash Flow of negative $64.0
million in the prior year. Free Cash Flow was up
significantly due to the factors mentioned above for the second
quarter.
Net Debt as at June 30, 2024 was $1,723.1 million, a
decrease of $84.3 million compared to
the prior year.
For further discussion on key operational metrics and results
refer to the section titled Operating Review.
Note: Several items
are excluded from the discussions of underlying earnings
performance as they are not representative of ongoing operational
activities. Refer to the section entitled Non-IFRS Financial
Measures at the end of this news release for a description and
reconciliation of all non-IFRS financial
measures.
|
Operating Review
During the first quarter of 2024, the Company announced an
update to its strategic blueprint (the "Blueprint") that reflects
the progress it has made toward achieving its Purpose and Vision
and establishes the roadmap for the next chapter for how Maple Leaf
Foods intends to deliver on these objectives.
As part of delivering on these objectives, the Company combined
its Meat and Plant protein businesses and aligned its
organizational structure to focus on growth potential in key
markets and drive operational efficiencies. As a result in the
first quarter of 2024, Maple Leaf Foods began to report its
business and operational results as a consolidated protein company,
and updated its Adjusted EBITDA margin target of 14% - 16% to
include Plant protein.
As a consolidated protein company, Maple Leaf Foods has two
operating units: Prepared Foods and Pork, which represent on
average approximately 75% and 25% of total Company revenue
respectively. Prepared Foods combines the operations of prepared
meats, plant protein, and poultry, which represent on average
approximately 50%, 5% and 20% of total Company revenue
respectively.
The following table summarizes the Company's sales, gross
profit, SG&A, Adjusted Operating Earnings, Adjusted
EBITDA, Adjusted EBITDA Margin, and Adjusted EBT for the three and
six months ended June 30, 2024 and June 30, 2023.
|
Three months ended
June 30,
|
Six months ended
June 30,
|
($ millions except
where noted otherwise)
(Unaudited)
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Sales(i)
|
|
$
1,260.9
|
|
$
1,265.8
|
|
$
2,414.1
|
|
$
2,436.9
|
Gross profit
(loss)
|
|
$
131.2
|
|
$
93.6
|
|
$
357.5
|
|
$
170.0
|
Selling, general and
administrative expenses
|
|
$
116.6
|
|
$
106.2
|
|
$
226.7
|
|
$
208.9
|
Adjusted Operating
Earnings(ii)
|
|
$
78.1
|
|
$
45.9
|
|
$
131.1
|
|
$
65.2
|
Adjusted
EBITDA(ii)
|
|
$
140.9
|
|
$
103.1
|
|
$
257.3
|
|
$
178.4
|
Adjusted EBITDA
Margin(i)(ii)
|
|
11.2 %
|
|
8.1 %
|
|
10.7 %
|
|
7.3 %
|
Adjusted
EBT(i)
|
|
$
34.4
|
|
$
6.7
|
|
$
44.8
|
|
$
(7.3)
|
|
|
(i)
|
Quarterly amounts
for 2023 have been adjusted to eliminate new sales agreements
entered into during the year that contained an expectation of
repurchase, which had previously been reported as external
sales.
|
(ii)
|
Refer to the section
titled Non-IFRS Financial Measures in this news
release.
|
Sales for the second quarter decreased 0.4% to $1,260.9 million, compared to $1,265.8 million last year. Sales in the Prepared
Foods operating unit increased approximately 1.0%, with prepared
meats increasing 3.2% offset by declines in poultry and plant
protein of 3.9% and 2.5% respectively. Sales in the Pork operating
unit decreased by 4.2% compared to last year. Favourable mix shift
and food service volumes drove the increase in sales in prepared
meats, while decreases in fresh poultry volume were driven by
reduced sales to industrial channels with repatriation of volume to
the London poultry facility partly
offset by mix and retail growth. Plant protein sales continued to
decline in line with the overall plant protein market. Pork sales
declined with lower buy to sell volumes and a negative foreign
exchange impact.
Year-to-date sales for 2024 decreased 0.9% to $2,414.1 million compared to $2,436.9 million last year. The decline in sales
was driven by factors consistent with those mentioned above and a
reduction in hog purchases for processing in the first quarter of
2024.
Gross profit for the second quarter increased to
$131.2 million, (gross
margin(i) of 10.4%) compared to $93.6 million (gross margin of 7.4%) last year.
The improvement in gross profit was driven by improving pork market
conditions, reduced start-up expenses in the London Poultry
facility and Bacon Centre of Excellence, and improved operational
efficiencies across the network, all of which were partially offset
by unrealized mark to market valuation adjustment on biological
assets due to changes in hog and feed markets.
Year-to-date gross profit for 2024 was $357.5 million (gross margin of 14.8%) compared
to $170.0 million (gross margin of
7.0%) last year. Gross profit improvement was driven by improving
pork market conditions, reduced start-up expenses in the
London poultry facility and Bacon
Centre of Excellence, operational efficiencies, and unrealized
gains on mark to market of biological assets driven by changes in
hog and feed markets.
SG&A expenses for the second quarter were $116.6 million, compared to $106.2 million last year. The increase in
SG&A expenses was primarily driven by higher variable
compensation and higher consulting fees.
Year-to-date SG&A expenses for 2024 were $226.7 million compared to $208.9 million last year. The increase in
SG&A expenses was driven by factors similar to those noted
above.
Adjusted Operating Earnings for the second quarter
were $78.1 million, compared to $45.9
million last year, driven primarily by the drivers noted
above for gross profit and SG&A, and excluding the impacts of
unrealized mark to market valuation adjustments and start-up
expenses, which are excluded in the calculation of Adjusted
Operating Earnings.
Year-to-date Adjusted Operating Earnings for 2024 were
$131.1 million compared to
$65.2 million last year, consistent
with factors noted above.
Adjusted EBITDA for the second quarter were $140.9 million, compared to $103.1 million last year, driven by factors
consistent with those noted above and also excluding the impact of
unrealized mark to market valuation adjustments and start-up
expenses. Adjusted EBITDA Margin for the second quarter of 2024 was
11.2% compared to 8.1% last year, also driven by factors consistent
with those noted above.
Year-to-date Adjusted EBITDA for 2024 were $257.3 million compared to $178.4 million last year, driven by factors
consistent with those noted above. Year-to-date Adjusted EBITDA
Margin for 2024 was 10.7% compared to 7.3% last year, also
driven by factors consistent with those noted above.
Adjusted EBT for the second quarter were $34.4 million, compared to $6.7 million last year, driven by factors
consistent with those noted above, partially offset by a
$6.1 million increase in interest
expense as a result of higher interest rates and also excluding the
impacts of unrealized mark to market valuation adjustments and
start-up expenses.
Year-to-date Adjusted EBT were $44.8
million compared to a loss of $7.3
million last year, driven by factors consistent with those
noted above, as well as a $16.6
million increase in interest expense as a result of higher
interest rates and higher debt levels.
Other Matters
On August 7, 2024, the Board of
Directors approved a quarterly dividend of $0.22 per share, $0.88 per share on an annual basis, payable
September 27, 2024 to shareholders of
record at the close of business September 6,
2024. Unless indicated otherwise by the Company at or before
the time the dividend is paid, the dividend will be considered an
eligible dividend for the purposes of the "Enhanced Dividend Tax
Credit System". The Board of Directors has also approved the
issuance of common shares from treasury at a two percent discount
under the Company's Dividend Reinvestment Plan ("DRIP"). Under the
DRIP, investors holding the Company's common shares can receive
common shares instead of cash dividend payments. Further details,
including how to enroll in the program are available at
https://www.mapleleaffoods.com/investors/stock-information.com.
Conference Call
A conference call will be held at 9:00 a.m. ET on
August 8, 2024, to review Maple Leaf Foods' second quarter
financial results. To participate in the call, please dial
289-819-1350 or 1-800-836-8184. For those unable to participate,
playback will be made available an hour after the event at
289-819-1450 or 1-888-660-6345 (Passcode: 01201#).
A webcast of the second quarter conference call will also be
available at:
https://www.mapleleaffoods.com/investors/events-and-presentations/
The Company's full unaudited condensed consolidated interim
financial statements ("Consolidated Interim Financial Statements")
and related Management's Discussion and Analysis are available on
the Company's website and on SEDAR+ at www.sedarplus.ca.
An investor presentation related to the Company's second quarter
financial results is available at www.mapleleaffoods.com under
Presentations and Webcasts on the Investors page.
Outlook
Maple Leaf Foods is a leading consumer protein company built on
a powerful portfolio of brands, with a leading voice in
sustainability and food security. The Company's strategic Blueprint
defines how it will advance its vision to be the Most Sustainable
Protein Company on Earth while delivering on its commercial and
financial objectives.
The Company recognizes that macro-economic factors and global
conflict continue to define the current operating environment,
contributing to higher interest rates, inflation, supply chain
tensions, and pressures on agricultural, commodity and foreign
exchange markets. As a result, consumers and businesses alike are
adapting their behaviour which impacts demand and product mix. The
Company leverages its data-driven insights to stay close to these
dynamics, and it is confident in the resilience of its brands,
business model and strategy to manage through prevailing economic
conditions.
Earlier this year, Maple Leaf Foods refreshed its Blueprint and
announced it was realigning its organizational structure to support
its new strategic orientation as it brings together its Meat and
Plant Protein businesses under a single umbrella with a clear and
consistent focus on driving profitable growth in Canada, the U.S., and internationally across
its entire protein portfolio.
With this focus, the Company expects to achieve an overall
consolidated Adjusted EBITDA margin target of 14% to 16% in normal
market conditions. Prior to this year, this Adjusted EBITDA margin
target applied to the previous Meat Protein segment but now applies
on a consolidated protein basis.
For the full year 2024, the Company expects:
- Low single-digit revenue growth
- Adjusted EBITDA margin expansion from 2023, supported by the
benefits of:
- Profitable growth of its leading portfolio of protein
brands
- Returns from investments in the London Poultry Plant and the
Bacon Centre of Excellence
- Leadership in sustainable meats
- Driving operational and cost efficiencies
- To generate increased Free Cash Flow and delever its balance
sheet by:
- Improving margins and overall profitability as outlined
above
- Generating the targeted returns on its capital investments at
the London Poultry Plant and the Bacon Centre of Excellence,
including reducing start-up expenses, maximizing efficiencies and
onboarding new customers
- Exercising disciplined capital management, with total capital
expenditures this year expected to be in the range of $120 - $140
million, largely focused on maintenance capital and
optimization of its existing network
Maple Leaf Foods will also continue to advance its ambitious
sustainability agenda, including leading the real food movement,
advancing its animal care initiatives, seeking solutions to address
food insecurity, accelerating its efforts to reduce its
environmental footprint and continuing to deliver safe food made in
a safe work environment.
On July 9, 2024, Maple Leaf Foods
announced plans to separate into two independent public companies
through the spin-off of its pork business. The Company expects that
this transaction will be completed in 2025.
Non-IFRS Financial Measures
The Company uses the following non-IFRS measures: Adjusted
Operating Earnings, Adjusted Earnings per Share, Adjusted EBITDA,
Adjusted EBITDA Margin, Adjusted EBT, Construction Capital, Net
Debt, Net Debt to trailing four quarters Adjusted EBITDA, Free Cash
Flow and Return on Net Assets. Management believes that these
non-IFRS measures provide useful information to investors in
measuring the financial performance of the Company for the reasons
outlined below. These measures do not have a standardized meaning
prescribed by IFRS and therefore they may not be comparable to
similarly titled measures presented by other publicly traded
companies and should not be construed as an alternative to other
financial measures determined in accordance with IFRS.
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA
Margin and Adjusted EBT
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA
Margin and Adjusted EBT are non-IFRS measures used by Management to
evaluate financial operating results. Adjusted Operating Earnings
is defined as earnings before other income, income taxes and
interest expense adjusted for items that are not considered
representative of ongoing operational activities of the business
and certain items where the economic impact of the transactions
will be reflected in earnings in future periods when the underlying
or related asset is sold or transferred. Adjusted EBITDA is defined
as Adjusted Operating Earnings plus depreciation and intangible
asset amortization, adjusted for items included in other expense
that are considered representative of ongoing operational
activities of the business. Adjusted EBITDA Margin is calculated as
Adjusted EBITDA divided by sales. Adjusted EBT is used annually by
the Company to evaluate its performance and is a component of
calculating bonus entitlements under the Company's short term
incentive plan. It is defined as Adjusted EBITDA plus interest
income, less depreciation and amortization, and interest
expense.
The table below provides a reconciliation of earnings (loss)
before income taxes as reported under IFRS in the Consolidated
Interim Financial Statements to Adjusted Operating Earnings,
Adjusted EBITDA and Adjusted EBT for the three and six months ended
June 30, 2024 as indicated below. Management believes that
these non-IFRS measures are useful in assessing the performance of
the Company's ongoing operations and its ability to generate cash
flows to fund its requirements, including the Company's capital
investment program.
|
Three months ended
June 30,
|
Six months ended
June 30,
|
($
millions)(i) (Unaudited)
|
2024
|
2023
|
2024
|
2023
|
Earnings (loss)
before income taxes
|
$
(32.5)
|
$
(63.7)
|
$
41.3
|
$
(133.7)
|
Interest expense and
other financing costs
|
43.6
|
37.6
|
85.7
|
69.2
|
Other expense
(income)
|
(3.5)
|
2.6
|
(2.3)
|
6.9
|
Restructuring and other
related costs
|
6.9
|
11.0
|
6.2
|
18.8
|
Earnings (loss) from
operations
|
$
14.5
|
$
(12.6)
|
$
130.8
|
$
(38.9)
|
Start-up expenses from
Construction Capital(ii)
|
4.4
|
33.8
|
15.8
|
68.5
|
Change in fair value of
biological assets
|
52.5
|
27.5
|
(16.7)
|
28.7
|
Unrealized and deferred
(gain) loss on derivative contracts
|
6.8
|
(2.8)
|
1.1
|
6.8
|
Adjusted Operating
Earnings
|
$
78.1
|
$
45.9
|
$
131.1
|
$
65.2
|
Depreciation and
amortization(v)
|
63.7
|
59.7
|
128.6
|
117.4
|
Items included in other
income (expense) representative
of
ongoing operations(iii)
|
(0.9)
|
(2.5)
|
(2.4)
|
(4.1)
|
Adjusted
EBITDA
|
$
140.9
|
$
103.1
|
$
257.3
|
$
178.4
|
Adjusted EBITDA
Margin(iv)
|
11.2 %
|
8.1 %
|
10.7 %
|
7.3 %
|
Interest expense and
other financing costs
|
(43.6)
|
(37.6)
|
(85.7)
|
(69.2)
|
Interest
income
|
0.8
|
0.8
|
1.8
|
0.8
|
Depreciation and
amortization
|
(63.7)
|
(59.7)
|
(128.6)
|
(117.4)
|
Adjusted
EBT
|
$
34.4
|
$
6.7
|
$
44.8
|
$
(7.3)
|
(i)
|
Totals may not add
due to rounding.
|
(ii)
|
Start-up expenses
are temporary costs as a result of operating new facilities that
are or were previously classified as Construction Capital. These
costs can include training, product testing, yield and labour
efficiency variances, duplicative overheads including depreciation
and other temporary expenses required to ramp-up
production.
|
(iii)
|
Primarily includes
certain costs associated with sustainability projects, gains and
losses on the impairment and sale of long-term assets, legal
settlements, gains and losses on investments, and other
miscellaneous expenses.
|
(iv)
|
Quarterly amounts
for 2023 have been adjusted to eliminate new sales agreements
entered into during the year that contained an expectation of
repurchase, which had previously been reported as external
sales.
|
(v)
|
Depreciation
included in start-up expenses is excluded from this
line.
|
Adjusted Earnings per Share
Adjusted Earnings per Share, a non-IFRS measure, is used by
Management to evaluate financial operating results. It is defined
as basic earnings per share and is adjusted on the same basis as
Adjusted Operating Earnings. The table below provides a
reconciliation of basic earnings per share as reported under
IFRS in the Consolidated Interim Financial Statements to Adjusted
Earnings per Share for the three and six months ended June 30 as indicated below. Management believes
this basis is the most appropriate on which to evaluate financial
results as they are representative of the ongoing operations of the
Company.
($ per
share)
(Unaudited)
|
Three months ended
June 30,
|
Six months ended
June 30,
|
2024
|
2023
|
2024
|
2023
|
Basic (loss) earnings
per share
|
|
$
(0.21)
|
|
$
(0.44)
|
|
$
0.21
|
|
$
(0.92)
|
Restructuring and other
related costs(i)
|
|
0.04
|
|
0.08
|
|
0.04
|
|
0.14
|
Items included in other
expense not considered representative of ongoing
operations(ii)
|
|
(0.03)
|
|
0.01
|
|
(0.02)
|
|
0.02
|
Start-up expenses from
Construction Capital(iii)
|
|
0.03
|
|
0.21
|
|
0.10
|
|
0.42
|
Change in fair value of
biological assets
|
|
0.31
|
|
0.17
|
|
(0.12)
|
|
0.18
|
Change in unrealized
and deferred fair value on derivatives
|
|
0.04
|
|
(0.02)
|
|
0.01
|
|
0.04
|
Adjusted Earnings
per Share
|
|
$
0.18
|
|
$
0.00
|
|
$
0.22
|
|
$
(0.12)
|
|
|
(i)
|
Includes per share
impact of restructuring and other related costs, net of
tax.
|
(ii)
|
Primarily includes
legal fees and settlements, gains or losses on investment property,
and transaction related costs, net of tax.
|
(iii)
|
Start-up expenses
are temporary costs as a result of operating new facilities that
are or have been classified as Construction Capital. These costs
can include training, product testing, yield and labour efficiency
variances, duplicative overheads and other temporary expenses
required to ramp-up production, net of tax.
|
Construction Capital
Construction Capital, a non-IFRS measure, is used by Management
to evaluate the amount of capital resources invested in specific
strategic development projects that are not yet operational. It is
defined as investments and related financing charges in projects
over $50.0 million that are related
to longer-term strategic initiatives, with no returns expected for
at least 12 months from commencement of construction and the asset
is re-categorized from Construction Capital once operational.
Construction Capital balance was nil as at December 31, 2023, and there was no activity
during 2024. The Construction Capital activity for the six months
ended June 30, 2023 is shown in the table below.
($
thousands)
(Unaudited)
|
|
2023
|
Property and
equipment and intangibles at January 1
|
|
$
2,663,985
|
Other capital and
intangible assets at January 1(i)
|
|
2,654,419
|
Construction Capital
at January 1
|
|
$
9,566
|
Additions
|
|
8,822
|
Construction Capital
at March 31
|
|
$
18,388
|
Additions
|
|
18,896
|
Construction
Capital at June 30(ii)
|
|
$
37,284
|
Other capital and
intangible assets at June 30(i)
|
|
2,598,055
|
Property and
equipment and intangibles at June 30
|
|
$
2,635,339
|
|
|
|
Construction Capital
debt financing(iii)(iv)
|
|
$
36,589
|
|
|
(i)
|
Other capital and
intangible assets consists of property and equipment and
intangibles that do not meet the definition of Construction
Capital.
|
(ii)
|
As at June 30,
2023 the net book value of Construction Capital
includes $0.5 million related to intangible assets.
|
(ii)
|
June 30, 2023 does
not include $1,011.3 million in capital that has been transferred
out but is still in the start-up stage.
|
(iv)
|
Assumed to be fully
funded by debt to the extent that the Company has Net Debt
outstanding. Construction Capital debt financing excludes interest
paid and capitalized.
|
Net Debt
The following table reconciles Net Debt and Net Debt to trailing
four quarters Adjusted EBITDA to amounts reported under IFRS in the
Company's Consolidated Interim Financial Statements as at
June 30 as indicated below. The
Company calculates Net Debt as cash and cash equivalents, less
current and long-term debt and bank indebtedness. Management
believes this measure is useful in assessing the amount of
financial leverage employed.
($
thousands)
(Unaudited)
|
|
As at June
30,
|
|
2024
|
|
2023
|
Cash and cash
equivalents
|
|
$
158,381
|
|
$
156,859
|
Current portion of
long-term debt
|
|
$
(300,371)
|
|
$
(398,394)
|
Long-term
debt
|
|
(1,581,093)
|
|
(1,565,822)
|
Total
debt
|
|
$
(1,881,464)
|
|
$(1,964,216)
|
Net
Debt
|
|
$(1,723,083)
|
|
$(1,807,357)
|
Adjusted EBITDA for
the six months ended
|
|
$
257,310
|
|
$
178,430
|
Trailing four
quarters Adjusted EBITDA(i)
|
|
$
506,468
|
|
$
310,411
|
Net Debt to trailing
four quarters Adjusted EBITDA
|
|
3.4
|
|
5.8
|
|
|
(i)
|
Trailing four
quarters includes Q3 2023, Q4 2023, Q1 2024 and Q2 2024 for 2024;
and Q3 2022, Q4 2022, Q1 2023 and Q2 2023 for 2023.
|
Free Cash Flow
Free Cash Flow, a non-IFRS measure, is used by Management to
evaluate cash flow after investing in the maintenance of the
Company's asset base. It is defined as cash provided by operations,
less Maintenance Capital(i) and associated
interest paid and capitalized. The following table calculates Free
Cash Flow for the periods indicated below:
($
thousands)
(Unaudited)
|
Three months ended
June 30,
|
Six months ended
June 30,
|
|
2024
|
2023
|
|
2024
|
|
2023
|
Cash provided by (used
in) operating activities
|
|
$
45,496
|
$ (57,004)
|
|
$
132,821
|
|
$ (21,290)
|
Maintenance
Capital(i)
|
|
(18,250)
|
(19,070)
|
|
(31,686)
|
|
(42,178)
|
Interest paid and
capitalized related to Maintenance
Capital
|
|
(220)
|
(252)
|
|
(483)
|
|
(486)
|
Free Cash
Flow
|
|
$
27,026
|
$ (76,326)
|
|
$
100,652
|
|
$ (63,954)
|
(i)
|
Maintenance Capital
is defined as non-discretionary investment required to maintain the
Company's existing operations and competitive position. For the
three and six months ended June 30, 2024, total capital spending of
$16.3 million and $40.1 million (2023: $55.9 million and $105.1
million) shown on the Consolidated Statements of Cash Flows is made
up of Maintenance Capital of $18.3 million and $31.7 million (2023:
$19.1 million and $42.2 million), and Growth Capital was a net cash
inflow of $2.0 million for the three months ended June 30, 2024 as
a result of government grants received during the second quarter
and Growth Capital was a net outflow of $8.4 million for the six
months ended June 30, 2024 (2023: $36.8 million and $62.9 million).
Growth Capital is defined as discretionary investment meant to
create stakeholder value through initiatives that for example,
expand margins, increase capacities or create further competitive
advantage
|
Return on Net Assets ("RONA")
RONA is calculated by dividing tax effected earnings from
operations (adjusted for items which are not considered
representative of the underlying operations of the business) by
average monthly net assets. Net assets are defined as total assets
(excluding cash and deferred tax assets) less non-interest bearing
liabilities (excluding deferred tax liabilities). Management
believes that RONA is an appropriate basis upon which to evaluate
long-term financial performance.
Forward-Looking Statements
This document contains, and the Company's oral and written
public communications often contain, "forward-looking information"
within the meaning of applicable securities law. These statements
are based on current expectations, estimates, projections, beliefs,
judgements and assumptions based on information available at the
time the applicable forward-looking statement was made and in light
of the Company's experience combined with its perception of
historical trends. Such statements include, but are not limited to,
statements with respect to objectives and goals, in addition to
statements with respect to beliefs, plans, targets, goals,
objectives, expectations, anticipations, estimates, and intentions.
Forward-looking statements are typically identified by words such
as "anticipate", "continue", "estimate", "expect", "may", "will",
"project", "should", "could", "would", "believe", "plan", "intend",
"design", "target", "undertake", "view", "indicate", "maintain",
"explore", "entail", "schedule", "objective", "strategy", "likely",
"potential", "outlook", "aim", "propose", "goal", and similar
expressions suggesting future events or future performance. These
statements are not guarantees of future performance and involve
assumptions, risks and uncertainties that are difficult to
predict.
By their nature, forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause
actual results or events to differ materially from those
anticipated in such forward-looking statements. The Company
believes the expectations reflected in the forward-looking
statements are reasonable, but no assurance can be given that these
expectations will prove to be correct and such forward-looking
statements should not be unduly relied upon.
Specific forward-looking information in this document may
include, but is not limited to, statements with respect to:
- timing, approvals, expected structure, expected benefits,
risks, and tax implications associated with the proposed spin-off
of the Pork business announced on July 9,
2024 (the "Spin-Off");
- the anticipated future financial performance of the businesses
following the Spin-Off, including post separation business
structure and the ability of each company to execute their
respective business and sustainability strategies;
- assumptions about the economic environment, including the
implications of inflationary pressures on customer and consumer
behaviour, supply chains, global conflicts and competitive
dynamics;
- expected future cash flows and the sufficiency thereof, sources
of capital at attractive rates, future contractual obligations,
future financing options, renewal of credit facilities, compliance
with credit facility covenants, and availability of capital to fund
growth plans, operating obligations and dividends;
- future performance, including future financial objectives,
goals and targets, category growth analysis, expected capital spend
and expected SG&A expenditures, global pork market dynamics,
Japan export market margin
outlook, labour markets, inflationary pressures (including the
ability to price for inflation);
- potential for a recurrence of a cybersecurity incident on the
Company's systems, business and operations, as well as the ability
to mitigate the financial and operational impacts, the success of
remediation and recovery efforts, the implications of data
breaches, and other ongoing risks associated with
cybersecurity;
- the execution of the Company's business strategy, including the
development and expected timing of business initiatives, brand
expansion and repositioning, plant protein category investment and
performance, market access in China and Japan, capital allocation decisions (including
investment in share repurchases under the NCIB) and investment in
potential growth opportunities and the expected returns associated
therewith;
- the impact of international trade conditions and markets on the
Company's business, including access to markets, global conflict
and other social, economic and political factors that affect
trade;
- implications associated with the spread of foreign animal
disease (such as African Swine Fever ("ASF")) and other animal
diseases such as Avian Influenza;
- competitive conditions and the Company's ability to position
itself competitively in the markets in which it competes;
- capital projects, including planning, construction, estimated
expenditures, schedules, approvals, expected capacity, in-service
dates and anticipated benefits of construction of new facilities
and expansions of existing facilities;
- the Company's dividend policy, including future levels and
sustainability of cash dividends, the tax treatment thereof and
future dividend payment dates;
- the impact of commodity prices and foreign exchange impacts on
the Company's operations and financial performance, including the
use and effectiveness of hedging instruments;
- operating risks, including the execution, monitoring and
continuous improvement of the Company's food safety programs,
animal health initiatives, cost reduction initiatives, and service
levels (including service level penalties);
- the implementation, cost and impact of environmental
sustainability initiatives, the ability of the Company to achieve
its sustainability objectives, changing climate and sustainability
laws and regulation, changes in customer and consumer expectations
related to sustainability matters, as well as the anticipated
future cost of remediating environmental liabilities;
- the adoption of new accounting standards and the impact of such
adoption on the financial position of the Company;
- expectations regarding pension plan performance, including
future pension plan assets, liabilities and contributions; and
- developments and implications of actual or potential legal
actions.
Various factors or assumptions are typically applied by the
Company in drawing conclusions or making the forecasts,
projections, predictions or estimations set out in the
forward-looking statements. These factors and assumptions are based
on information currently available to the Company, including
information obtained by the Company from third-party sources and
include but are not limited to the following:
- expectations and assumptions concerning the timing and
completion of the proposed spin-off of the Pork business announced
on July 9, 2024;
- expectations regarding the adaptations in operations, supply
chain, customer and consumer behaviour, economic patterns
(including but not limited to global pork markets), foreign
exchange rates, international trade dynamics and access to capital,
including possible presence or absence of structural changes
associated with the economic recovery since the pandemic and global
conflicts;
- the competitive environment, associated market conditions and
market share metrics, category growth or contraction, the expected
behaviour of competitors and customers and trends in consumer
preferences;
- the success of the Company's business strategy and the
relationship between pricing, inflation, volume and sales of the
Company's products;
- prevailing commodity prices (especially in pork and feed
markets), interest rates, tax rates and exchange rates;
- potential impacts related to cybersecurity matters, including
security costs, the potential for a future incident, the risks
associated with data breaches, the availability of insurance, the
effectiveness of remediation and prevention activities, third party
activities, ongoing impacts, customer, consumer and supplier
responses and regulatory considerations;
- the economic condition of and the sociopolitical dynamics
between Canada, the U.S.,
Japan and China, and the ability of the Company to
access markets and source ingredients and other inputs in light of
global sociopolitical disruption, and the ongoing impact of global
conflicts on inflation, trade and markets;
- the spread of foreign animal disease (including ASF and Avian
Influenza), preparedness strategies to manage such spread, and
implications for all protein markets;
- the availability of and access to capital to fund future
capital requirements and ongoing operations;
- expectations regarding participation in and funding of the
Company's pension plans;
- the availability of insurance coverage to manage certain
liability exposures;
- the extent of future liabilities and recoveries related to
legal claims;
- prevailing regulatory, tax and environmental laws; and
- future operating costs and performance, including the Company's
ability to achieve operating efficiencies and maintain sales
volumes, turnover of inventories and turnover of accounts
receivable.
Readers are cautioned that these assumptions may prove to be
incorrect in whole or in part. The Company's actual results may
differ materially from those anticipated in any forward-looking
statements.
Factors that could cause actual results or outcomes to differ
materially from the results expressed, implied, or projected in the
forward-looking statements contained in this document include,
among other things, risks associated with the following:
- the spin-off of the Pork business not proceeding as expected
(within the expected timeline or at all), including as a result of
the conditions of the transaction not being satisfied,
- the spin-off of the Pork business not delivering the intended
benefits, including the ability of the separated companies to each
succeed as a standalone publicly trading company;
- unanticipated effects of the announcement and potential
spin-off on the market price for the Company's securities or the
financial performance of the Company;
- the results of each of the separated companies' execution of
their respective business plans, the degree to which benefits are
realized or not and the timing to realize those benefits, including
the implications on the financial results of each;
- presence or absence of adaptations or structural changes
arising since the economic recovery following the pandemic which
may have implications for the operations and financial performance
of the Company, as well the ongoing implications for macro
socio-economic trends and global conflict;
- macro economic trends, including inflation, consumer behaviour,
recessionary indicators, labour availability and labour market
dynamics and international trade trends (including global pork
markets);
- the results of the Company's execution of its business plans,
the degree to which benefits are realized or not, and the timing
associated realizing those benefits, including the implications on
cash flow;
- competition, market conditions, and the activities of
competitors and customers, including the expansion or contraction
of key categories, inflationary pressures, pork market dynamics and
Japan export margins;
- cybersecurity and maintenance and operation of the Company's
information systems, processes and data, recovery, restoration and
long term impacts of the cybersecurity event, the risk of future
cybersecurity events, actions of third parties, risks of data
breaches, effectiveness of business continuity planning and
execution, and availability of insurance;
- the health status of livestock, including the impact of
potential pandemics;
- international trade and access to markets and supplies, as well
as social, political and economic dynamics, including global
conflicts;
- operating performance, including manufacturing operating
levels, fill rates and penalties;
- availability of and access to capital, and compliance with
credit facility covenants;
- decisions respecting the return of capital to
shareholders;
- the execution of capital projects and investment maintenance
capital;
- food safety, consumer liability and product recalls;
- climate change, climate regulation and the Company's
sustainability performance;
- strategic risk management;
- acquisitions and divestitures;
- fluctuations in the debt and equity markets;
- fluctuations in interest rates and currency exchange
rates;
- pension assets and liabilities;
- cyclical nature of the cost and supply of hogs and the
competitive nature of the pork market generally;
- the effectiveness of commodity and interest rate hedging
strategies;
- impact of changes in the market value of the biological assets
and hedging instruments;
- the supply management system for poultry in Canada;
- availability of plant protein ingredients;
- intellectual property, including product innovation, product
development, brand strategy and trademark protection;
- consolidation of operations and focus on protein;
- the use of contract manufacturers;
- reputation;
- weather;
- compliance with government regulation and adapting to changes
in laws;
- actual and threatened legal claims;
- consumer trends and changes in consumer tastes and buying
patterns;
- environmental regulation and potential environmental
liabilities;
- consolidation in the retail environment;
- employment matters, including complying with employment laws
across multiple jurisdictions, the potential for work stoppages due
to non-renewal of collective agreements, recruiting and retaining
qualified personnel, reliance on key personnel and succession
planning;
- pricing of products;
- managing the Company's supply chain;
- changes in International Financial Reporting Standards and
other accounting standards that the Company is required to adhere
to for regulatory purposes; and
- other factors as set out under the heading "Risk Factors" in
the Company's Management Discussion and Analysis for the year ended
December 31, 2023.
The Company cautions readers that the foregoing list of factors
is not exhaustive.
Readers are further cautioned that some of the forward-looking
information, such as statements concerning future capital
expenditures, Adjusted EBITDA Margin expansion, and the Company's
ability to achieve its financial targets or projections may be
considered to be financial outlooks for purposes of applicable
securities legislation. These financial outlooks are presented to
evaluate potential future earnings and anticipated future uses of
cash flows and may not be appropriate for other purposes. Readers
should not assume these financial outlooks will be
achieved.
More information about risk factors can be found under the
heading "Risk Factors" in the Company's Annual Management's
Discussion and Analysis for the year ended December 31,
2023, that is available on SEDAR+ at www.sedarplus.ca. The reader
should review such section in detail. Additional information
concerning the Company, including the Company's Annual Information
Form, is available on SEDAR+ at www.sedarplus.ca.
All forward-looking statements included herein speak only as of
the date hereof. Unless required by law, the Company does not
undertake any obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. All forward-looking statements
contained herein are expressly qualified by this cautionary
statement.
Management's Estimates on the Pork business spin-off, and
related Non-IFRS measures
The following table presents management's preliminary estimates
of certain financial information regarding the new Pork Company and
the business that will be retained after the separation by Maple
Leaf Foods. These preliminary estimates have not been audited or
reviewed by any third party, have been derived from internal
management reporting, and reflect sales, cost and expense
allocations, including with respect to corporate expenses, as well
as other estimates and adjustments, each of which is preliminary in
nature and subject to change.
Management believes that these preliminary estimates are useful
in providing an indication of the relative size of the businesses
upon separation. Each of these figures is expected to be refined
prior to the separation, with full financial details to be
presented in the prospectus and management information circular to
be filed in connection with the transaction.
|
|
Last twelve months
ended June 30, 2024
|
|
(in millions of
Canadian dollars)
(unaudited)
|
|
New Pork
Company
|
|
|
Maple Leaf
Foods(i)
|
|
|
Eliminations
|
|
|
Consolidated
Maple Leaf Foods Inc.
|
|
Sales
|
|
$
1,661
|
(ii)
|
|
$
3,562
|
(iii)
|
|
$
(378)
|
(iv)
|
|
$
4,845
|
(v)
|
Adjusted
EBITDA
|
|
110
|
(vi)
|
|
396
|
(vii)
|
|
—
|
|
|
506
|
(v),(viii)
|
Adjusted EBITDA
Margin(ix)
|
|
6.6 %
|
|
|
11.1 %
|
|
|
— %
|
|
|
10.5 %
|
|
Estimate of potential
impact of
separation*
|
|
~$2 -
(2)
|
|
|
~$(3) -
(7)
|
|
|
|
|
|
|
|
Pro Forma Adjusted
EBITDA(xi)
|
|
~110
|
|
|
~390
|
|
|
|
|
|
|
|
Pro Forma Adjusted
EBITDA margin(xii)
|
|
~7%
|
|
|
~11%
|
|
|
|
|
|
|
|
Estimate of potential
market
normalization impact(xiii)
|
|
~80-85
|
|
|
|
|
|
|
|
|
|
|
Pro Forma normalized
Adjusted EBITDA(xiv)
|
|
~190
|
|
|
|
|
|
|
|
|
|
|
Pro Forma normalized
Adjusted
EBITDA Margin(xv)
|
|
~11%
|
|
|
|
|
|
|
|
|
|
|
|
|
Note:
|
|
i.
|
Refers to the business that will be retained after
the separation by Maple Leaf Foods Inc.
|
|
|
ii.
|
Represents management's preliminary estimate of sales
(both to Maple Leaf Foods and to external third parties)
attributable to the business that will be transferred to the new
Pork Company in the separation for the period
presented.
|
|
|
iii.
|
Represents management's preliminary estimate of sales
attributable to the business that will be retained by Maple Leaf
Foods after the separation for the period
presented.
|
|
|
iv.
|
Primarily represents management's preliminary
estimate of sales from the new Pork Company to Maple Leaf Foods for
the period presented.
|
|
|
v.
|
Calculated by adding the previously reported results
for the year ended December 31, 2023 to results for the six months
ended June 30, 2024 and subtracting results for the six months
ended June 30, 2023. These results are reported in the
Company's MD&A filed on SEDAR and SEDAR+ for the year ended
December 31, 2023, the quarter ended June 30, 2024 and the quarter
ended June 30, 2023.
|
|
|
vi.
|
Represents management's preliminary estimate of the
portion of consolidated Adjusted EBITDA attributable to the new
Pork Company for the period presented. As noted above, this
estimate is subject to change and is expected to be refined prior
to the separation.
|
|
|
vii.
|
Represents management's preliminary estimate of the
portion of consolidated Adjusted EBITDA attributable to Maple Leaf
Foods (as defined in note (i) above) for the period presented. As
noted above, this estimate is subject to change and is expected to
be refined prior to the separation.
|
|
|
viii.
|
For a definition of Adjusted EBITDA (consolidated),
and a reconciliation of Adjusted EBITDA (consolidated) for the
periods described in note (iv) above to consolidated net income for
such periods, see the Company's MD&A filed on SEDAR and SEDAR+
for the year ended December 31, 2023, the quarter ended June 30,
2024 and the quarter ended June 30, 2023.
|
|
|
ix.
|
Defined as Adjusted EBITDA divided by Sales. This
metric is subject to change and is expected to be refined prior to
the separation in the same manner as the metrics from which this
metric is derived, as noted above.
|
|
|
x.
|
Represents management's preliminary estimate of the
potential impact on Adjusted EBITDA of the new Pork Company and
Maple Leaf Foods (as defined in note (i) above), respectively, if
the separation had occurred on July 1, 2023. Primarily relates to
management's preliminary estimate of (1) a change in Adjusted
EBITDA of the new Pork Company and an offsetting change in Adjusted
EBITDA of Maple Leaf Foods as a result of the anticipated impact of
the supply agreement and other contractual arrangements expected to
be entered into in connection with the separation, (2) public
company costs that would have been incurred by the new Pork
Company, and (3) a reallocation of certain SG&A expenses from
the new Pork Company to Maple Leaf Foods. As noted above, this
estimate is subject to change and is expected to be refined prior
to the separation.
|
|
|
xi
|
Defined as Adjusted EBITDA plus management's
preliminary estimate of the potential impact of the separation
described in, and subject to the qualifications described in, note
(10) above.
|
|
|
xii.
|
Defined as Pro Forma Adjusted EBITDA, as described in
note (xi) above divided by Sales. This metric is subject to change
and is expected to be refined prior to the separation in the same
manner as the metrics from which this metric is derived, as noted
above.
|
|
|
xiii.
|
Presented for illustrative purposes only, based on
management estimates and assumptions, to indicate what the
potential impact on Pro Forma Adjusted EBITDA may have been if
market conditions during the period presented had reflected normal
market conditions, defined as the 5-year pre-pandemic (2015 – 2019)
average ("Normal Market Conditions"). Actual market conditions
during the period presented were materially different from Normal
Market Conditions, and there can be no assurance that actual Pro
Forma Adjusted EBITDA would have been impacted in the manner shown
if Normal Market Conditions had existed during the period
presented, or that actual future market conditions will reflect
Normal Market Conditions. This metric is not intended to be
indicative of potential financial results for any future
period.
|
|
|
xiv.
|
Defined as Pro Forma
Adjusted EBITDA, as described in note (xi) above, plus management's
preliminary estimate of the potential impact if market conditions
during the period presented had reflected Normal Market Conditions,
subject to the qualifications described in note (xiii) above. This
metric is presented for illustrative purposes only and is not
intended to be indicative of potential financial results for any
future period.
|
|
|
xv.
|
Defined as Pro Forma normalized Adjusted EBITDA, as
described in note (xiv) above, divided by Sales. This metric
is presented for illustrative purposes only and is based on
management estimates and assumptions. This metric is subject to
change and is expected to be refined prior to the separation in the
same manner as the metrics from which this metric is derived, as
noted above. Actual market conditions during the period presented
were materially different from Normal Market Conditions, and there
can be no assurance that actual Pro Forma Adjusted EBITDA Margin
would have been impacted in the manner shown if Normal Market
Conditions had existed during the period presented, or that actual
future market conditions will reflect Normal Market Conditions.
This metric is not intended to be indicative of potential financial
results for any future period.
|
Adjusted EBITDA, Pro Forma Adjusted EBITDA, and Pro Forma
normalized Adjusted EBITDA, and related margins, as presented in
the table above, are non-IFRS metrics and do not have a
standardized meaning prescribed by IFRS. Consequently, they
may not be comparable to similarly titled measures presented by
other publicly traded companies and should not be construed as an
alternative to other financial measures determined in accordance
with IFRS.
About Maple Leaf Foods Inc.
Maple Leaf Foods is a leading protein company responsibly
producing food products under leading brands including Maple
Leaf®, Maple Leaf Prime®, Maple Leaf Natural
Selections®, Schneiders®,
Schneiders® Country Naturals®,
Mina®, Greenfield Natural Meat Co.®,
Lightlife® and Field Roast™. The Company employs
approximately 13,500 people and does business primarily in
Canada, the U.S. and Asia. The Company is headquartered in
Mississauga, Ontario and its
shares trade on the Toronto Stock Exchange (MFI).
Consolidated Interim Balance Sheets
(In thousands of
Canadian dollars)
(Unaudited)
|
As at June
30,
2024
|
As at June 30,
2023
|
As at December
31,
2023
|
ASSETS
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
158,381
|
|
$
156,859
|
|
$
203,363
|
Accounts
receivable
|
|
184,300
|
|
205,930
|
|
183,798
|
Notes
receivable
|
|
44,886
|
|
48,159
|
|
33,220
|
Inventories
|
|
580,472
|
|
523,377
|
|
542,392
|
Biological
assets
|
|
124,688
|
|
111,796
|
|
114,917
|
Income taxes
recoverable
|
|
62,761
|
|
69,521
|
|
88,896
|
Prepaid expenses and
other assets
|
|
35,203
|
|
36,786
|
|
44,865
|
Assets held for
sale
|
|
27,438
|
|
11,204
|
|
—
|
Total current
assets
|
|
$ 1,218,129
|
|
$ 1,163,632
|
|
$ 1,211,451
|
Property and
equipment
|
|
2,186,520
|
|
2,285,314
|
|
2,251,710
|
Right-of-use
assets
|
|
171,692
|
|
150,211
|
|
154,610
|
Investments
|
|
16,112
|
|
22,869
|
|
15,749
|
Investment
property
|
|
34,744
|
|
5,289
|
|
57,144
|
Employee
benefits
|
|
116,800
|
|
49,699
|
|
26,785
|
Other long-term
assets
|
|
22,271
|
|
9,601
|
|
22,336
|
Deferred tax
asset
|
|
42,504
|
|
41,450
|
|
40,854
|
Goodwill
|
|
477,353
|
|
477,353
|
|
477,353
|
Intangible
assets
|
|
343,457
|
|
350,025
|
|
345,129
|
Total long-term
assets
|
|
$ 3,411,453
|
|
$ 3,391,811
|
|
$ 3,391,670
|
Total
assets
|
|
$ 4,629,582
|
|
$ 4,555,443
|
|
$ 4,603,121
|
LIABILITIES AND
EQUITY
|
|
|
|
|
|
|
Accounts payable and
accruals
|
|
$
543,792
|
|
$
528,481
|
|
$
548,444
|
Current portion of
provisions
|
|
9,673
|
|
23,837
|
|
9,846
|
Current portion of
long-term debt
|
|
300,371
|
|
398,394
|
|
400,735
|
Current portion of
lease obligations
|
|
40,544
|
|
37,749
|
|
38,031
|
Income taxes
payable
|
|
2,351
|
|
1,600
|
|
2,382
|
Other current
liabilities
|
|
24,986
|
|
17,998
|
|
32,974
|
Total current
liabilities
|
|
$
921,717
|
|
$ 1,008,059
|
|
$ 1,032,412
|
Long-term
debt
|
|
1,581,093
|
|
1,565,822
|
|
1,550,080
|
Lease
obligations
|
|
157,550
|
|
137,029
|
|
142,286
|
Employee
benefits
|
|
60,796
|
|
64,251
|
|
64,196
|
Provisions
|
|
1,998
|
|
2,281
|
|
2,041
|
Other long-term
liabilities
|
|
1,167
|
|
928
|
|
1,124
|
Deferred tax
liability
|
|
330,232
|
|
223,190
|
|
296,203
|
Total long-term
liabilities
|
|
$ 2,132,836
|
|
$ 1,993,501
|
|
$ 2,055,930
|
Total
liabilities
|
|
$ 3,054,553
|
|
$ 3,001,560
|
|
$ 3,088,342
|
Shareholders'
equity
|
|
|
|
|
|
|
Share
capital
|
|
$
886,876
|
|
$
859,046
|
|
$
873,477
|
Retained
earnings
|
|
640,589
|
|
671,870
|
|
597,429
|
Contributed
surplus
|
|
6,773
|
|
—
|
|
3,227
|
Accumulated other
comprehensive income
|
|
44,222
|
|
30,150
|
|
47,829
|
Treasury
shares
|
|
(3,431)
|
|
(7,183)
|
|
(7,183)
|
Total shareholders'
equity
|
|
$ 1,575,029
|
|
$ 1,553,883
|
|
$ 1,514,779
|
Total liabilities
and equity
|
|
$ 4,629,582
|
|
$ 4,555,443
|
|
$ 4,603,121
|
Consolidated Interim Statements of (Loss) Earnings
(In thousands of
Canadian dollars, except share amounts)
(Unaudited)
|
Three months ended
June 30,
|
Six months ended
June 30,
|
|
2024
|
|
2023(i)
|
|
2024
|
|
2023(i)
|
|
|
|
|
|
|
|
|
|
Sales
|
|
$
1,260,878
|
|
$ 1,265,841
|
|
$
2,414,103
|
|
$ 2,436,908
|
Cost of goods
sold
|
|
1,129,723
|
|
1,172,245
|
|
2,056,608
|
|
2,266,865
|
Gross profit
|
|
$
131,155
|
|
$
93,595
|
|
$
357,495
|
|
$
170,042
|
Selling, general and
administrative expenses
|
|
116,649
|
|
106,184
|
|
226,682
|
|
208,897
|
Earnings (loss) before
the following:
|
|
$
14,506
|
|
$ (12,589)
|
|
$
130,813
|
|
$ (38,855)
|
Restructuring and other
related costs
|
|
6,893
|
|
11,026
|
|
6,168
|
|
18,775
|
Other (income)
expense
|
|
(3,492)
|
|
2,579
|
|
(2,335)
|
|
6,874
|
Earnings (loss) before
interest and income taxes
|
|
$
11,105
|
|
$ (26,194)
|
|
$
126,980
|
|
$ (64,504)
|
Interest expense and
other financing costs
|
|
43,637
|
|
37,554
|
|
85,720
|
|
69,157
|
(Loss) earnings before
income taxes
|
|
$ (32,532)
|
|
$ (63,748)
|
|
$
41,260
|
|
$
(133,661)
|
Income tax (recovery)
expense
|
|
(6,359)
|
|
(10,070)
|
|
15,882
|
|
(22,279)
|
(Loss)
earnings
|
|
$ (26,173)
|
|
$ (53,678)
|
|
$
25,378
|
|
$
(111,382)
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per
share attributable to common
shareholders:
|
|
|
|
|
|
|
|
|
Basic (loss) earnings
per share
|
|
$
(0.21)
|
|
$
(0.44)
|
|
$
0.21
|
|
$
(0.92)
|
Diluted (loss)
earnings per share
|
|
$
(0.21)
|
|
$
(0.44)
|
|
$
0.20
|
|
$
(0.92)
|
Weighted average number
of shares (millions):
|
|
|
|
|
|
|
|
|
Basic
|
|
122.9
|
|
121.5
|
|
122.7
|
|
121.5
|
Diluted
|
|
122.9
|
|
121.5
|
|
123.8
|
|
121.5
|
(i)
|
Quarterly amounts
for 2023 have been adjusted see Note 17 in the condensed
consolidated interim financial statements.
|
Consolidated Interim Statements of Other Comprehensive Income
(Loss)
(In thousands of
Canadian dollars)
(Unaudited)
|
Three months ended
June 30,
|
Six months ended
June 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
|
|
|
|
|
|
(Loss)
earnings
|
|
$
(26,173)
|
|
$
(53,678)
|
|
$
25,378
|
|
$(111,382)
|
Other comprehensive
income
|
|
|
|
|
|
|
|
|
Actuarial gains
(losses) that will not be reclassified to profit or loss (Net of
tax of $22.5 million and $24.7 million; 2023: $8.9 million and $9.6
million)
|
|
$
65,346
|
|
$
25,779
|
|
$
71,951
|
|
$
27,903
|
Change in revaluation
surplus (2023: Net of tax of $0.0 million and
$1.7 million)
|
|
—
|
|
—
|
|
—
|
|
6,993
|
Total items that will
not be reclassified to profit or loss
|
|
$
65,346
|
|
$
25,779
|
|
$
71,951
|
|
$
34,896
|
Items that are or may
be reclassified subsequently to profit or loss:
|
|
|
|
|
|
|
|
|
Change in accumulated
foreign currency translation adjustment (Net of tax of $0.0 million
and $0.0 million; 2023: $0.0 million and $0.0 million)
|
|
3,401
|
|
(8,686)
|
|
11,111
|
|
(9,119)
|
Change in foreign
exchange on long-term debt designated as a net investment hedge
(Net of tax of $0.6 million and $1.8 million; 2023: $1.2 million
and $1.2 million)
|
|
(3,226)
|
|
6,498
|
|
(9,838)
|
|
6,618
|
Change in cash flow
hedges (Net of tax of $0.5 million and $0.7 million; 2023: $0.8
million and $1.8 million)
|
|
(1,258)
|
|
(782)
|
|
(4,880)
|
|
(3,889)
|
Total items that are or
may be reclassified subsequently to profit or loss
|
|
$
(1,083)
|
|
$
(2,970)
|
|
$
(3,607)
|
|
$
(6,390)
|
Total other
comprehensive income
|
|
$
64,263
|
|
$
22,809
|
|
$
68,344
|
|
$
28,506
|
Comprehensive income
(loss)
|
|
$
38,090
|
|
$
(30,869)
|
|
$
93,722
|
|
$ (82,876)
|
Consolidated Interim Statements of Changes in Total Equity
|
|
|
|
Accumulated other
comprehensive income (loss)
|
|
|
(In thousands of Canadian dollars)
|
Share
capital
|
Retained
earnings
|
Contributed
surplus
|
Foreign currency
translation adjustment(i)
|
Unrealized gains and
losses on cash flow hedges(i)
|
Unrealized gains on
fair value of investments(i)
|
Revaluation
surplus
|
Treasury
stock
|
Total
equity
|
Balance at December
31, 2023
|
$873,477
|
597,429
|
3,227
|
8,625
|
4,416
|
(2,559)
|
37,347
|
(7,183)
|
$1,514,779
|
Earnings
|
—
|
25,378
|
—
|
—
|
—
|
—
|
—
|
—
|
25,378
|
Other
comprehensive income (loss)(ii)
|
—
|
71,951
|
—
|
1,273
|
(4,880)
|
—
|
—
|
—
|
68,344
|
Dividends declared
($0.44 per share)
|
10,901
|
(54,169)
|
—
|
—
|
—
|
—
|
—
|
—
|
(43,268)
|
Share-based
compensation expense
|
—
|
—
|
11,387
|
—
|
—
|
—
|
—
|
—
|
11,387
|
Deferred taxes on
share-based compensation
|
—
|
—
|
(425)
|
—
|
—
|
—
|
—
|
—
|
(425)
|
Exercise of stock
options
|
2,498
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
2,498
|
Settlement of
share-based compensation
|
—
|
—
|
(7,416)
|
—
|
—
|
—
|
—
|
3,752
|
(3,664)
|
Balance at June 30,
2024
|
$886,876
|
640,589
|
6,773
|
9,898
|
(464)
|
(2,559)
|
37,347
|
(3,431)
|
$1,575,029
|
|
|
|
|
|
|
Accumulated other
comprehensive income (loss)
|
|
|
(In thousands of Canadian dollars)
|
Share
capital
|
Retained
earnings
|
Contributed
surplus
|
Foreign currency
translation adjustment
|
Unrealized gains and
losses on cash flow hedges
|
Unrealized gains on
fair value of investments
|
Revaluation
surplus
|
Treasury
stock
|
Total
equity
|
Balance at December 31,
2022
|
$850,086
|
809,616
|
—
|
10,972
|
12,885
|
2,945
|
2,745
|
(25,916)
|
$1,663,333
|
Loss
|
—
|
(111,382)
|
—
|
—
|
—
|
—
|
—
|
—
|
(111,382)
|
Other
comprehensive income (loss)(ii)
|
—
|
27,903
|
—
|
(2,501)
|
(3,889)
|
—
|
6,993
|
—
|
28,506
|
Dividends declared
($0.42 per share)
|
—
|
(51,252)
|
—
|
—
|
—
|
—
|
—
|
—
|
(51,252)
|
Share-based
compensation expense
|
—
|
—
|
6,062
|
—
|
—
|
—
|
—
|
—
|
6,062
|
Deferred taxes on
share-based compensation
|
—
|
—
|
1,100
|
—
|
—
|
—
|
—
|
—
|
1,100
|
Exercise of stock
options
|
4,447
|
—
|
(1,363)
|
—
|
—
|
—
|
—
|
—
|
3,084
|
Shares
re-purchased
|
(4,498)
|
—
|
(11,595)
|
—
|
—
|
—
|
—
|
—
|
(16,093)
|
Shares sold by RSU
trust
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
9,841
|
9,841
|
Settlement of
share-based compensation
|
—
|
(3,015)
|
(15,192)
|
—
|
—
|
—
|
—
|
8,892
|
(9,315)
|
Change in obligation
for repurchase of shares
|
9,011
|
—
|
20,988
|
—
|
—
|
—
|
—
|
—
|
29,999
|
Balance at June 30,
2023
|
$859,046
|
671,870
|
—
|
8,471
|
8,996
|
2,945
|
9,738
|
(7,183)
|
$1,553,883
|
|
|
(i)
|
Items that are or
may be subsequently reclassified to profit or loss.
|
(ii)
|
Included in other
comprehensive income (loss) is the change in actuarial gains and
losses that will not be reclassified to profit or loss and has been
reclassified to retained earnings.
|
Consolidated Interim Statements of Cash Flows
(In thousands of
Canadian dollars)
(Unaudited)
|
Three months ended
June 30,
|
Six months ended
June 30,
|
2024
|
2023
|
2024
|
2023
|
CASH PROVIDED BY (USED
IN):
|
|
|
|
|
Operating
activities
|
|
|
|
|
|
|
|
|
(Loss)
earnings
|
|
$ (26,173)
|
|
$ (53,678)
|
|
$
25,378
|
|
$
(111,382)
|
Add (deduct) items not
affecting cash:
|
|
|
|
|
|
|
|
|
Change in fair value
of biological assets
|
|
52,488
|
|
27,547
|
|
(16,655)
|
|
28,674
|
Depreciation and
amortization
|
|
64,446
|
|
66,371
|
|
130,299
|
|
133,796
|
Share-based
compensation
|
|
6,089
|
|
4,050
|
|
11,387
|
|
6,062
|
Deferred income tax
(recovery) expense
|
|
(8,843)
|
|
(5,144)
|
|
11,093
|
|
(8,018)
|
Current income tax
(recovery) expense
|
|
2,484
|
|
(4,926)
|
|
4,789
|
|
(14,261)
|
Interest expense and
other financing costs
|
|
43,637
|
|
37,554
|
|
85,720
|
|
69,157
|
(Gain) loss on sale of
long-term assets
|
|
(1,326)
|
|
741
|
|
(1,637)
|
|
975
|
Impairment of property
and equipment and ROU assets
|
|
118
|
|
6,530
|
|
118
|
|
6,530
|
Change in fair value
of investment property
|
|
(5,038)
|
|
—
|
|
(5,038)
|
|
—
|
Change in fair value
of non-designated
derivatives
|
|
2,991
|
|
(8,635)
|
|
(1,674)
|
|
(5,526)
|
Change in net pension
obligation
|
|
2,169
|
|
(136)
|
|
3,236
|
|
331
|
Net income taxes
refunded (paid)
|
|
18,764
|
|
3,143
|
|
21,746
|
|
1,366
|
Interest paid, net of
capitalized interest
|
|
(32,459)
|
|
(33,838)
|
|
(72,936)
|
|
(67,628)
|
Change in provision
for restructuring and other
related costs
|
|
3,087
|
|
(13,545)
|
|
(173)
|
|
(19,551)
|
Change in derivatives
margin
|
|
(1,075)
|
|
8,454
|
|
1,241
|
|
(5,286)
|
Cash settlement of
derivatives
|
|
(728)
|
|
(2,735)
|
|
(2,878)
|
|
8,274
|
Other
|
|
2,231
|
|
(3,913)
|
|
5,324
|
|
(3,696)
|
Change in non-cash
operating working capital
|
|
(77,366)
|
|
(84,844)
|
|
(66,519)
|
|
(41,107)
|
Cash provided by (used
in) operating activities
|
|
$
45,496
|
|
$ (57,004)
|
|
$ 132,821
|
|
$ (21,290)
|
Investing
activities
|
|
|
|
|
|
|
|
|
Additions to long-term
assets
|
|
$ (16,318)
|
|
$ (55,869)
|
|
$ (40,131)
|
|
$
(105,121)
|
Interest paid and
capitalized
|
|
(219)
|
|
(757)
|
|
(574)
|
|
(1,238)
|
Proceeds from sale of
long-term assets
|
|
2,631
|
|
206
|
|
3,496
|
|
270
|
Purchase of
investments
|
|
—
|
|
(100)
|
|
—
|
|
(100)
|
Cash used in investing
activities
|
|
$ (13,906)
|
|
$ (56,520)
|
|
$ (37,209)
|
|
$
(106,189)
|
Financing
activities
|
|
|
|
|
|
|
|
|
Dividends
paid
|
|
$ (21,607)
|
|
$ (25,693)
|
|
$ (43,268)
|
|
$ (51,252)
|
Net (decrease)
increase in long-term debt
|
|
(50,480)
|
|
219,554
|
|
(81,365)
|
|
268,354
|
Payment of lease
obligation
|
|
(7,891)
|
|
(7,462)
|
|
(16,337)
|
|
(17,380)
|
Exercise of stock
options
|
|
2,498
|
|
2,315
|
|
2,498
|
|
3,084
|
Repurchase of
shares
|
|
—
|
|
(5,324)
|
|
—
|
|
(16,093)
|
Sale (purchase) of
treasury shares
|
|
—
|
|
9,841
|
|
—
|
|
9,841
|
Payment of financing
fees
|
|
(2,122)
|
|
(2,281)
|
|
(2,122)
|
|
(3,292)
|
Cash (used in) provided
by financing activities
|
|
$ (79,602)
|
|
$ 190,950
|
|
$
(140,594)
|
|
$ 193,262
|
(Decrease) increase
in cash and cash equivalents
|
|
$ (48,012)
|
|
$
77,426
|
|
$ (44,982)
|
|
$
65,783
|
Cash and cash
equivalents, beginning of period
|
|
206,393
|
|
79,433
|
|
203,363
|
|
91,076
|
Cash and cash
equivalents, end of period
|
|
$ 158,381
|
|
$ 156,859
|
|
$ 158,381
|
|
$ 156,859
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/maple-leaf-foods-reports-second-quarter-2024-financial-results-302217759.html
SOURCE Maple Leaf Foods Inc.